Episode Summary
Prof Shankar Siva discusses The Management of Stage III NSCLC in this podcast. Prof Shankar is joined by A/Prof Rachel Wong and Prof Drew Moghanaki. Our focus today is on what defines inoperable NSCLC, patient selection and how to manage the toxicities associated with treatment.
Thank you to AstraZeneca for sponsoring this podcast.
Show Hosts
This episode’s host are:
- Prof Shankar Siva, Radiation Oncologist; current Cancer Council Victoria (CCV) Colebatch Fellow
- A/Prof Rachel Wong, Deputy Director of Oncology, Eastern Health; Adjunct Clinical Associate Professor, Monash University; Clinical research Fellow, Walter and Eliza Hall Institute of Medical Research
- Dr Drew Moghanaki, Chief of Thoracic Oncology, Department of Radiation Oncology, University of California Los Angeles; Stanley Lezman and Nancy Stark Endowed Chair in Thoracic Radiation Oncology Research; Co-Director, Great Los Angeles Lung Cancer Precision Oncology Program; Co-Director, Great Los Angeles CSP NODES Program
